Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis - 26/09/23
Résumé |
Mastocytosis is characterized by expansion and activation of clonally aberrant mast cells (MCs) in one or more organ systems. Inappropriate MC activation is a key finding in both allergy and mastocytosis; therefore, symptoms in both conditions show some degree of overlap. When mediator release is excessive and involves multiple systems, anaphylaxis may occur. In mastocytosis, the prevalence of atopy is similar to those of the general population, whereas the incidence of anaphylaxis is significantly higher. The purpose of this review is to discuss features of allergy and anaphylaxis as well as the principles of managing MC mediator release symptoms in mastocytosis.
Le texte complet de cet article est disponible en PDF.Keywords : Atopy, Anaphylaxis, KIT D816V, Mastocytosis, Tryptase, Mediator release symptoms, Hereditary alpha-tryptasemia, MCAS
Plan
Vol 43 - N° 4
P. 681-698 - novembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?